Microplate Dx Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series A
- (Upcoming)
- Latest Deal Amount
-
$13.3M
- Investors
-
17
Microplate Dx General Information
Description
Developer of rapid diagnostic technologies designed to detect antimicrobial resistance and guide antibiotic treatment decisions. The company offers rapid antibiotic susceptibility testing, infectious disease diagnostics, point-of-care testing solutions, biosensor-based diagnostic platforms, and antimicrobial stewardship tools, enabling clinicians to identify effective antibiotics and treat infections more quickly and accurately.
Contact Information
Website
www.microplatedx.comCorporate Office
- Royal College Building, 204 George Street
- Suite 534
- Glasgow G1 1XW
- Scotland, United Kingdom
Corporate Office
- Royal College Building, 204 George Street
- Suite 534
- Glasgow G1 1XW
- Scotland, United Kingdom
Microplate Dx Timeline
Microplate Dx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. Early Stage VC (Series A) | $13.3M | Upcoming | Product In Beta Test | |||
| 18. Accelerator/Incubator | 23-Mar-2026 | Completed | Startup | |||
| 17. Early Stage VC | 08-Sep-2025 | Completed | Product In Beta Test | |||
| 16. Accelerator/Incubator | 06-Jun-2025 | Completed | Product In Beta Test | |||
| 15. Grant | 06-Feb-2025 | Completed | Product In Beta Test | |||
| 14. Grant | 01-Dec-2024 | Completed | Product In Beta Test | |||
| 13. Grant | Completed | Product In Beta Test | ||||
| 12. Early Stage VC | 01-Feb-2024 | Completed | Product In Beta Test | |||
| 11. Secondary Transaction - Private | $3.8M | Completed | Product In Beta Test | |||
| 10. Seed Round | 11-Sep-2023 | $3.16M | $3.8M | Completed | Product In Beta Test |
Microplate Dx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Microplate Dx Comparisons
Industry
Financing
Details
Microplate Dx Competitors (5)
One of Microplate Dx’s 5 competitors is SpeeDx, a Venture Capital-Backed company based in Sydney, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SpeeDx | Venture Capital-Backed | Sydney, Australia | ||||
| FluoretiQ | Venture Capital-Backed | Bristol, United Kingdom | ||||
| DeepUll | Venture Capital-Backed | Barcelona, Spain | ||||
| iFAST | Venture Capital-Backed | Fareham, United Kingdom | ||||
| Sysmex Astrego | Formerly VC-backed | Uppsala, Sweden |
Microplate Dx Patents
Microplate Dx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202416505-D0 | A method and system for identifying microbes | Pending | 08-Nov-2024 | ||
| GB-2702578-A | A method and system for identifying microbes | Pending | 08-Nov-2024 | ||
| WO-2026099465-A1 | A method and system for identifying microbes | Pending | 08-Nov-2024 | ||
| EP-4713472-A1 | A system for identifying microbial growth | Pending | 16-May-2023 | ||
| GB-202307287-D0 | A system for identifying microbial growth | Active | 16-May-2023 | C12M1/3407 |
Microplate Dx Signals
Microplate Dx Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Future4care | Accelerator/Incubator | |||
| MedTech Innovator | Accelerator/Incubator | |||
| SBRI Healthcare | Government | |||
| National Institute for Health Research Invention for Innovation | Government | |||
| Impact Venture | Family Office | Minority |
Microplate Dx FAQs
-
When was Microplate Dx founded?
Microplate Dx was founded in 2021.
-
Where is Microplate Dx headquartered?
Microplate Dx is headquartered in Glasgow, United Kingdom.
-
What is the size of Microplate Dx?
Microplate Dx has 15 total employees.
-
What industry is Microplate Dx in?
Microplate Dx’s primary industry is Diagnostic Equipment.
-
Is Microplate Dx a private or public company?
Microplate Dx is a Private company.
-
What is Microplate Dx’s current revenue?
The current revenue for Microplate Dx is .
-
How much funding has Microplate Dx raised over time?
Microplate Dx has raised $14.3M.
-
Who are Microplate Dx’s investors?
Future4care, MedTech Innovator, SBRI Healthcare, National Institute for Health Research Invention for Innovation, and Impact Venture are 5 of 17 investors who have invested in Microplate Dx.
-
Who are Microplate Dx’s competitors?
SpeeDx, FluoretiQ, DeepUll, iFAST, and Sysmex Astrego are competitors of Microplate Dx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process